These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2787696)
1. Synthesis of site-specific methotrexate-IgG conjugates. Comparison of stability and antitumor activity with active-ester-based conjugates. Kralovec J; Singh M; Mammen M; Blair AH; Ghose T Cancer Immunol Immunother; 1989; 29(4):293-302. PubMed ID: 2787696 [TBL] [Abstract][Full Text] [Related]
2. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates. Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities. Kralovec J; Spencer G; Blair AH; Mammen M; Singh M; Ghose T J Med Chem; 1989 Nov; 32(11):2426-31. PubMed ID: 2810330 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of carbohydrate-linked murine monoclonal antibody K20-human serum albumin conjugates. Kondejewski LH; Kralovec JA; Blair AH; Ghose T Bioconjug Chem; 1994; 5(6):602-11. PubMed ID: 7873663 [TBL] [Abstract][Full Text] [Related]
5. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor. Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053 [TBL] [Abstract][Full Text] [Related]
6. Hydrolysis of methotrexate-immunoglobulin conjugates by liver homogenates and characterization of catabolites. Uadia PO; Blair AH; Ghose T Cancer Chemother Pharmacol; 1988; 22(2):175-7. PubMed ID: 3409449 [TBL] [Abstract][Full Text] [Related]
7. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo. Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133 [TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of methotrexate-immunoglobulin conjugates. Ghosh MK; Kildsig DO; Mitra AK Drug Des Deliv; 1989 Jan; 4(1):13-25. PubMed ID: 2789065 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicities of two disulfide-bond-linked conjugates of methotrexate with monoclonal anti-MM46 antibody. Umemoto N; Kato Y; Hara T Cancer Immunol Immunother; 1989; 28(1):9-16. PubMed ID: 2783302 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumour activity of aminopterin-monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate-monoclonal antibody conjugates. Kanellos J; Pietersz GA; Cunningham Z; McKenzie IF Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():483-93. PubMed ID: 3502340 [TBL] [Abstract][Full Text] [Related]
11. The influence of synthetic conditions on the stability of methotrexate-monoclonal antibody conjugates determined by reversed phase high performance liquid chromatography. Hudecz F; Garnett MC; Khan T; Baldwin RW Biomed Chromatogr; 1992; 6(3):128-32. PubMed ID: 1525486 [TBL] [Abstract][Full Text] [Related]
12. Conjugation of methotrexate to IgG antibodies and their F(ab)2 fragments and the effect of conjugated methotrexate on tumor growth in vivo. Kulkarni PN; Blair AH; Ghose T; Mammen M Cancer Immunol Immunother; 1985; 19(3):211-4. PubMed ID: 3847291 [TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody. Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T Cancer Res; 1987 Feb; 47(4):1076-80. PubMed ID: 3802092 [TBL] [Abstract][Full Text] [Related]
14. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system. Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723 [TBL] [Abstract][Full Text] [Related]
15. Lipophilic methotrexate conjugates with antitumor activity. Pignatello R; Spampinato G; Sorrenti V; Di Giacomo C; Vicari L; McGuire JJ; Russell CA; Puglisi G; Toth I Eur J Pharm Sci; 2000 May; 10(3):237-45. PubMed ID: 10767601 [TBL] [Abstract][Full Text] [Related]
16. Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary. Pietersz GA; Cunningham Z; McKenzie IF Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():43-9. PubMed ID: 3372005 [TBL] [Abstract][Full Text] [Related]
17. The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3. Rowland AJ; Harper ME; Wilson DW; Griffiths K Br J Cancer; 1990 May; 61(5):702-8. PubMed ID: 2337507 [TBL] [Abstract][Full Text] [Related]
18. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line. Uadia P; Blair AH; Ghose T; Ferrone S J Natl Cancer Inst; 1985 Jan; 74(1):29-35. PubMed ID: 3855485 [TBL] [Abstract][Full Text] [Related]
19. Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer. Singh M; Ghose T; Faulkner G; Kralovec J; Mezei M Cancer Res; 1989 Jul; 49(14):3976-84. PubMed ID: 2660984 [TBL] [Abstract][Full Text] [Related]
20. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells. Shen WC; Ballou B; Ryser HJ; Hakala TR Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]